OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Development of high-affinity fluorinated ligands for cannabinoid subtype 2 receptor, and in vitro evaluation of a radioactive tracer for imaging
Daniel Modemann, Andhika B. Mahardhika, Sabrina Yamoune, et al.
European Journal of Medicinal Chemistry (2022) Vol. 232, pp. 114138-114138
Closed Access | Times Cited: 6
Daniel Modemann, Andhika B. Mahardhika, Sabrina Yamoune, et al.
European Journal of Medicinal Chemistry (2022) Vol. 232, pp. 114138-114138
Closed Access | Times Cited: 6
Showing 6 citing articles:
Evaluation of cannabinoid type 2 receptor expression and pyridine-based radiotracers in brains from a mouse model of Alzheimer’s disease
Vasil Kecheliev, Francesco Spinelli, Adrienne Müller Herde, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 11
Vasil Kecheliev, Francesco Spinelli, Adrienne Müller Herde, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 11
Development of the High-Affinity Carborane-Based Cannabinoid Receptor Type 2 PET Ligand [18F]LUZ5-d8
Lea Ueberham, Daniel Gündel, Martin Kellert, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 7, pp. 5242-5260
Open Access | Times Cited: 6
Lea Ueberham, Daniel Gündel, Martin Kellert, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 7, pp. 5242-5260
Open Access | Times Cited: 6
Synthesis, Structure–Activity Relationships, Radiofluorination, and Biological Evaluation of [18F]RM365, a Novel Radioligand for Imaging the Human Cannabinoid Receptor Type 2 (CB2R) in the Brain with PET
Rodrigo Teodoro, Daniel Gündel, Winnie Deuther‐Conrad, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 20, pp. 13991-14010
Open Access | Times Cited: 6
Rodrigo Teodoro, Daniel Gündel, Winnie Deuther‐Conrad, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 20, pp. 13991-14010
Open Access | Times Cited: 6
Potent, Selective Agonists for the Cannabinoid-like Orphan G Protein-Coupled Receptor GPR18: A Promising Drug Target for Cancer and Immunity
Andhika B. Mahardhika, Michał Załuski, Clara T. Schoeder, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 12, pp. 9896-9926
Closed Access | Times Cited: 1
Andhika B. Mahardhika, Michał Załuski, Clara T. Schoeder, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 12, pp. 9896-9926
Closed Access | Times Cited: 1
Design, synthesis, and structure–activity relationships of diindolylmethane derivatives as cannabinoid CB2 receptor agonists
Andhika B. Mahardhika, Anastasiia Ressemann, Sarah Kremers, et al.
Archiv der Pharmazie (2022) Vol. 356, Iss. 3
Open Access | Times Cited: 5
Andhika B. Mahardhika, Anastasiia Ressemann, Sarah Kremers, et al.
Archiv der Pharmazie (2022) Vol. 356, Iss. 3
Open Access | Times Cited: 5
Evaluation of CB2R expression and pyridine-based radiotracers in brains from a mouse model of Alzheimer’s disease
Vasil Kecheliev, Francesco Spinelli, Adrienne Müller Herde, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Vasil Kecheliev, Francesco Spinelli, Adrienne Müller Herde, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
